9,537
Total Claims
$2.0M
Drug Cost
511
Beneficiaries
$3,990
Cost/Patient
Peer Comparison vs. 7,389 General Practice providers
-89%
Opioid rate vs peers
0.3% vs 2.5% avg
+254%
Cost per patient vs peers
$3,990 vs $1,128 avg
+173%
Brand preference vs peers
22.9% vs 8.4% avg
Opioid Prescribing
0.3%
Opioid Rate
26
Opioid Claims
$270
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
77% generic
Brand: 2,171 claims · $1.7M
Generic: 7,297 claims · $363K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 382 | $437K |
| Dapagliflozin Propanediol | 207 | $216K |
| Lipase/Protease/Amylase | 194 | $215K |
| Sitagliptin Phosphate | 171 | $189K |
| Metformin Hcl | 20 | $95K |
| Budesonide/Formoterol Fumarate | 146 | $76K |
| Lipase/Protease/Amylase | 47 | $64K |
| Semaglutide | 39 | $51K |
| Apixaban | 45 | $50K |
| Icosapent Ethyl | 79 | $43K |
| Linagliptin | 40 | $42K |
| Semaglutide | 25 | $34K |
| Tenofovir Alafenamide | 16 | $31K |
| Diclofenac Sodium | 349 | $29K |
| Icosapent Ethyl | 57 | $26K |
Prescribing Profile
Patient Profile
72
Avg Age
51%
Female
1.09
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data